-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Voyager Therapeutics, Lowers Price Target to $25

Benzinga·11/12/2025 18:44:27
Listen to the news
HC Wainwright & Co. analyst Patrick R. Trucchio maintains Voyager Therapeutics (NASDAQ:VYGR) with a Buy and lowers the price target from $30 to $25.